Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Reimbursement For Shockwave’s IVL Device May Pose Quandary For CMS

Executive Summary

A temporary reimbursement boost for Shockwave’s C2 coronary intravascular lithotripsy (IVL) is coming to an end. John Leppard, Senior Healthcare Analyst & VP at Washington Analysis breaks down what that means for CMS. 

You may also be interested in...



Diagnostics Reform Reintroduced in House

The VALID Act, which will hand diagnostics oversight to the US FDA, has been reintroduced in the House of Representatives after it failed twice last year in Congress.

‘Refuse to Accept’ Decisions For Cyber Devices To Begin In October

The US FDA is giving sponsors a grace period of six months before it will issue “refuse to accept” decisions for premarket submissions for cyber devices that lack the information required under recent cyber amendments.

FDA Issues Framework For Use Of Digital Health Technologies In Drug Development

The FDA’s new framework for the use of digital health technologies will engage stakeholders to provide more guidelines for the industry.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

MT147704

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel